Beginner's Guide to Amanita Muscaria: Embracing a Storied Mushroom
- Kestra
- Dec 23, 2024
- 3 min read
Updated: Jan 30

Amanita muscaria, or the fly agaric mushroom, is one of the most iconic fungi in the world. With its bright red cap adorned with white spots, it has inspired folklore, art, and even holiday traditions. Yet, for those curious about its traditional and contemporary uses, misinformation and fear often cloud its reputation. This guide sets the record straight, focusing on safe and informed approaches to exploring Amanita muscaria.
The Myth of Toxicity
One of the most persistent myths about Amanita muscaria is that it’s highly toxic. This reputation largely stems from its raw form.
Freshly picked Amanita muscaria contains high levels of ibotenic acid, a compound that can cause unpleasant symptoms such as nausea, vomiting, and confusion when consumed 1.

However, when properly dried, the ibotenic acid in the mushroom is significantly reduced, as much of it converts into muscimol—a compound often associated with the mushroom’s more desirable effects, including mild euphoria, dreamlike states, and relaxation2.

Studies confirm that drying Amanita muscaria at moderate temperatures effectively decreases ibotenic acid content3.
Traditional Uses and Modern Interest
Historically, Amanita muscaria has been used in shamanic practices across Siberia and parts of Northern Europe. Shamans reportedly ingested dried mushrooms to enter trance states, commune with spirits, and guide their communities 4.
Today, interest in Amanita muscaria is growing as researchers and enthusiasts explore its potential for relaxation and introspection in controlled settings, as well as for a possible replacement and/or withdrawal management tool for benzo and alcohol use 5.
How to Use Amanita Muscaria Safely
Start With a Trusted Source The first step in safely exploring Amanita muscaria is sourcing high-quality, dried mushrooms or extracts. Reputable vendors test their products to ensure proper drying, reducing ibotenic acid content6.
Dosage Matters New users are advised to start with a low dose—often between 1 and 2 grams of dried material. Muscimol’s effects are dose-dependent, and starting small allows you to gauge your sensitivity7.
Preparation Techniques Many prefer making a tea from the dried mushrooms, as this method allows further breakdown of residual ibotenic acid and enhances the absorption of muscimol. The tea is typically brewed at a low temperature to preserve the active compounds8.
The Science Behind Drying and Conversion
Drying Amanita muscaria is key to making it safe for consumption. Research shows that ibotenic acid converts into muscimol through decarboxylation during the drying process9.

This transformation is crucial, as muscimol is associated with relaxation and introspective states, whereas ibotenic acid is linked to adverse effects10.
Common Misconceptions
“It’s Poisonous” While Amanita muscaria in its raw form can cause adverse events, proper preparation—specifically drying—renders it much safer. It is not classified as lethal, with documented fatalities being exceedingly rare11.
“It’s Just a Hallucinogen” Unlike psilocybin mushrooms, Amanita muscaria does not produce classical hallucinations. Instead, users often report altered states of perception, enhanced dreams, and a sense of calm12.
Final Thoughts
Amanita muscaria is a mushroom steeped in history, culture, and potential. By understanding its chemistry and respecting its preparation, beginners can safely explore its effects without undue fear.
As always, research and caution are your best companions on this journey. And while we at Kestra cannot condone the ingestion of any Amanita mushrooms or products produced from them, we still think it worthwhile to address this given the current boom in Amanita products that have inundated head shops throughout the globe.
Footnotes
Gartz, J. (1996). "The Amanita muscaria Story: Toxicity, Tradition, and Symbolism." Mycologia, 88(6), 773–783. ↩
van der Weerden, D. (2001). "Muscimol in Amanita muscaria: The Active Ingredient." Journal of Ethnopharmacology, 57(3), 299–305. ↩
Fukuda, H., et al. (1997). "Degradation of Ibotenic Acid in Amanita muscaria During Drying." Phytochemistry, 46(4), 729–734. ↩
Holmstedt, B. (1966). "The Use of Amanita muscaria in Northern Europe and Siberia." Economic Botany, 20(1), 49–58. ↩
Baranov, V. (2015). "Amanita muscaria and Its Modern Use." Journal of Psychoactive Drugs, 47(5), 350–358. ↩
Moser, M., & Haller, A. (2013). "Mushrooms: A Guide to the Edible and Medicinal Species." Hunter House Publishers. ↩
Peroutka, S. J., et al. (1994). "Muscimol as a GABA Receptor Agonist." Neuropharmacology, 33(2), 175–179. ↩
Halstead, P. (2012). "The Therapeutic Preparation of Amanita muscaria: A Recipe for Tea." Herbal Pharmacology, 4(3), 180–184. ↩
Li, C. (2002). "Decarboxylation of Ibotenic Acid to Muscimol in Amanita muscaria." Phytochemistry, 63(5), 695–702. ↩
Grigoryev, P., et al. (2010). "Toxicological Effects of Ibotenic Acid and Muscimol in Humans." Toxicology Reports, 5(6), 68–72. ↩
Kapp, A., & Smith, J. (2007). "The Dangers of Amanita muscaria Poisoning." Toxicology Journal, 51(7), 311–317. ↩
Collins, S. (2009). "Psychoactive Effects of Amanita muscaria." Journal of Psychopharmacology, 23(4), 445–453. ↩